Sumathy Mathialagan

1.6k total citations
41 papers, 1.3k citations indexed

About

Sumathy Mathialagan is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Cancer Research. According to data from OpenAlex, Sumathy Mathialagan has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 12 papers in Pediatrics, Perinatology and Child Health and 11 papers in Cancer Research. Recurrent topics in Sumathy Mathialagan's work include Drug Transport and Resistance Mechanisms (25 papers), Pharmacological Effects and Toxicity Studies (11 papers) and NF-κB Signaling Pathways (10 papers). Sumathy Mathialagan is often cited by papers focused on Drug Transport and Resistance Mechanisms (25 papers), Pharmacological Effects and Toxicity Studies (11 papers) and NF-κB Signaling Pathways (10 papers). Sumathy Mathialagan collaborates with scholars based in United States, Finland and Japan. Sumathy Mathialagan's co-authors include Manthena V. S. Varma, Nandini Kishore, A. David Rodrigues, Catherine S. Tripp, Bo Feng, David A. Tess, Yi‐An Bi, Sheri L. Bonar, Julia A. Guzova and Chester Costales and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Hypertension.

In The Last Decade

Sumathy Mathialagan

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sumathy Mathialagan United States	21	643	341	313	300	274	41	1.3k
Rajgopal Govindarajan United States	26	539 0.8×	883 2.6×	276 0.9×	128 0.4×	147 0.5×	49	2.1k
Bernard P. Murray United States	24	575 0.9×	540 1.6×	166 0.5×	761 2.5×	110 0.4×	61	2.0k
Maria Thomas Germany	26	422 0.7×	823 2.4×	212 0.7×	342 1.1×	416 1.5×	62	2.1k
Jason R. Manro United States	14	556 0.9×	420 1.2×	104 0.3×	323 1.1×	191 0.7×	28	1.3k
Julie Bullock United States	17	515 0.8×	467 1.4×	69 0.2×	278 0.9×	130 0.5×	26	1.6k
Patrick Caron Canada	30	770 1.2×	778 2.3×	207 0.7×	595 2.0×	91 0.3×	80	2.4k
Manfred G. Ismair Switzerland	12	957 1.5×	272 0.8×	84 0.3×	265 0.9×	90 0.3×	15	1.3k
Katrin Singer Germany	17	632 1.0×	702 2.1×	541 1.7×	107 0.4×	458 1.7×	30	1.7k
Mayumi Saeki Japan	23	722 1.1×	730 2.1×	56 0.2×	483 1.6×	154 0.6×	58	1.7k
Kathleen Köck United States	21	991 1.5×	311 0.9×	61 0.2×	358 1.2×	92 0.3×	28	1.5k

Countries citing papers authored by Sumathy Mathialagan

Since Specialization

Citations

This map shows the geographic impact of Sumathy Mathialagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumathy Mathialagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumathy Mathialagan more than expected).

Fields of papers citing papers by Sumathy Mathialagan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumathy Mathialagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumathy Mathialagan. The network helps show where Sumathy Mathialagan may publish in the future.

Co-authorship network of co-authors of Sumathy Mathialagan

This figure shows the co-authorship network connecting the top 25 collaborators of Sumathy Mathialagan. A scholar is included among the top collaborators of Sumathy Mathialagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumathy Mathialagan. Sumathy Mathialagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mathialagan, Sumathy, et al.. (2025). Pyridoxic Acid as Endogenous Biomarker of Renal Organic Anion Transporter Activity: Population Variability and Mechanistic Modeling to Predict Drug–Drug Interactions. CPT Pharmacometrics & Systems Pharmacology. 14(5). 904–917. 1 indexed citations

Bi, Yi‐An, Amanda King‐Ahmad, Mark A. West, et al.. (2024). Low Molecular Weight Acids and Organic Anion Transporting Polypeptide (OATP1B)-Mediated Hepatic Clearance: In Vitro and In Vivo Evaluation Using Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (Dustats). Drug Metabolism and Disposition. 52(5). 399–407. 1 indexed citations

Plotka, Anna, Julia Kaplan, Vivek S. Purohit, et al.. (2023). Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter Activity. Pharmaceutical Research. 40(11). 2639–2651. 3 indexed citations

Weng, Yan, Kari R. Fonseca, Yi‐An Bi, et al.. (2022). Transporter-Enzyme Interplay in the Pharmacokinetics of PF-06835919, a First-In-Class Ketohexokinase Inhibitor for Metabolic Disorders and Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 50(9). 1312–1321. 6 indexed citations

Prasad, Bhagwat, et al.. (2021). In Vitro–to–In Vivo Extrapolation of Transporter-Mediated Renal Clearance: Relative Expression Factor Versus Relative Activity Factor Approach. Drug Metabolism and Disposition. 49(6). 470–478. 24 indexed citations

Mathialagan, Sumathy, Yi‐An Bi, Chester Costales, et al.. (2020). Nicotinic acid transport into human liver involves organic anion transporter 2 (SLC22A7). Biochemical Pharmacology. 174. 113829–113829. 31 indexed citations

Luo, Lina, Ragu Ramanathan, Sumathy Mathialagan, et al.. (2020). A Multiplexed HILIC-MS/HRMS Assay for the Assessment of Transporter Inhibition Biomarkers in Phase I Clinical Trials: Isobutyryl-Carnitine as an Organic Cation Transporter (OCT1) Biomarker. Analytical Chemistry. 92(14). 9745–9754. 28 indexed citations

Bi, Yi‐An, Chester Costales, Sumathy Mathialagan, et al.. (2019). Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: “SLC-Phenotyping” Using Primary Human Hepatocytes. Journal of Pharmacology and Experimental Therapeutics. 370(1). 72–83. 66 indexed citations

Kimoto, Emi, Sumathy Mathialagan, Laurie Tylaska, et al.. (2018). Organic Anion Transporter 2–Mediated Hepatic Uptake Contributes to the Clearance of High-Permeability–Low-Molecular-Weight Acid and Zwitterion Drugs: Evaluation Using 25 Drugs. Journal of Pharmacology and Experimental Therapeutics. 367(2). 322–334. 46 indexed citations

10.

Bi, Yi‐An, Sumathy Mathialagan, Laurie Tylaska, et al.. (2018). Organic Anion Transporter 2 Mediates Hepatic Uptake of Tolbutamide, a CYP2C9 Probe Drug. Journal of Pharmacology and Experimental Therapeutics. 364(3). 390–398. 32 indexed citations

11.

Bajaj, Piyush, A. David Rodrigues, Claire M. Steppan, et al.. (2018). Human Pluripotent Stem Cell–Derived Kidney Model for Nephrotoxicity Studies. Drug Metabolism and Disposition. 46(11). 1703–1711. 15 indexed citations

12.

Bi, Yi‐An, Renato J. Scialis, Sarah Lazzaro, et al.. (2017). Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes. The AAPS Journal. 19(3). 787–796. 39 indexed citations

13.

Li, Rui, Yi‐An Bi, Anna Vildhede, et al.. (2017). Transporter-Mediated Disposition, Clinical Pharmacokinetics and Cholestatic Potential of Glyburide and Its Primary Active Metabolites. Drug Metabolism and Disposition. 45(7). 737–747. 10 indexed citations

14.

Xie, Jin, Gennadiy Poda, Yiding Hu, et al.. (2010). Aminopyridinecarboxamide-based inhaled IKK-2 inhibitors for asthma and COPD: Structure–activity relationship. Bioorganic & Medicinal Chemistry. 19(3). 1242–1255. 14 indexed citations

15.

Bonafoux, D., Sheri L. Bonar, Michael Clare, et al.. (2009). Aminopyridinecarboxamide-based inhibitors: Structure–activity relationship. Bioorganic & Medicinal Chemistry. 18(1). 403–414. 6 indexed citations

16.

Mbalaviele, Gabriel, Cynthia D. Sommers, Sheri L. Bonar, et al.. (2009). A Novel, Highly Selective, Tight Binding IκB Kinase-2 (IKK-2) Inhibitor: A Tool to Correlate IKK-2 Activity to the Fate and Functions of the Components of the Nuclear Factor-κB Pathway in Arthritis-Relevant Cells and Animal Models. Journal of Pharmacology and Experimental Therapeutics. 329(1). 14–25. 56 indexed citations

17.

Bonafoux, D., Sheri L. Bonar, Michael Clare, et al.. (2005). Inhibition of IKK-2 by 2-[(aminocarbonyl)amino]-5-acetylenyl-3-thiophenecarboxamides. Bioorganic & Medicinal Chemistry Letters. 15(11). 2870–2875. 24 indexed citations

18.

Kishore, Nandini, Sumathy Mathialagan, Julia A. Guzova, et al.. (2003). A Selective IKK-2 Inhibitor Blocks NF-κB-dependent Gene Expression in Interleukin-1β-stimulated Synovial Fibroblasts. Journal of Biological Chemistry. 278(35). 32861–32871. 247 indexed citations

19.

Huynh, Q K, et al.. (2002). Kinetic Mechanisms of IκB-related Kinases (IKK) Inducible IKK and TBK-1 Differ from IKK-1/IKK-2 Heterodimer. Journal of Biological Chemistry. 277(15). 12550–12558. 22 indexed citations

20.

Kishore, Nandini, Q K Huynh, Sumathy Mathialagan, et al.. (2002). IKK-i and TBK-1 are Enzymatically Distinct from the Homologous Enzyme IKK-2. Journal of Biological Chemistry. 277(16). 13840–13847. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact